Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Core Binding Factor Acute Myeloid Leukemia × avapritinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myeloid, Acute 4 Neoplasm Metastasis 2 Mastocytosis, Systemic 2 Sarcoma 1 Recurrence 1 Melanoma 1 Lung Neoplasms 1 Leukemia, Mast-Cell 1 Core Binding Factor Acute Myeloid Leukemia 1 Colorectal Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05821738 2023-05-09

Avapritinib in CBF-AML With KIT Mutations

The First Affiliated Hospital of Soochow University

Phase 2 Unknown

MyeloidOther hematologic neoplasm

Core Binding Factor Acute Myeloid Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡